Deniz Yucel

Dr. Deniz Yucel


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2021 in Macromolecular Bioscience
Verified
Journal Article
Closed access
PDF file
TUTugba Dursun Usal
Tugba Dursun Usal
MYMetin Yesiltepe
Metin Yesiltepe
DYDeniz Yucel
Deniz Yucel
YSYıldırım Sara
Yıldırım Sara
Vasif HasirciVasif Hasirci
Vasif Hasirci

27 March 2025 in Macromolecular Bioscience
Verified
Journal Article
Open access
DBDeniz Basoz
Deniz Basoz
AAAslihan Akalinli
Aslihan Akalinli
SBSenem Buyuksungur
Senem Buyuksungur
ACA. R. Cenk Celebi
A. R. Cenk Celebi
DYDeniz Yucel
Deniz Yucel
Vasif HasirciVasif Hasirci
Vasif Hasirci
Many people lose their vision due to corneal stroma injuries of the eye and the golden solution is transplantation of allografts from donors. Unfortunately, the limited availability of donor tissue, risk of disease transmission, and immune rejection are serious handicaps. However, implants made of biomaterials can be used as substitutes. In this study, cell‐loaded and cell‐free, methacrylated gelatin (GelMA) implants are 3D printed and tested under in vitro conditions. The samples are physically characterized for their printability, equilibrium water content, compressive mechanical strength, and transparency; they retained 60%–80% of light transmission in the visible region as in the native corneas. In brief, they are suitable for further testing. Then cell loaded samples are tested in vivo on New Zealand white rabbits for 90 days. In the in vivo tests, these cell loaded, disk shaped implants are almost completely degraded and allowed reorganization of the tissue forming at the implantation site. Also, the immune response initially observed decreased in time and by the end of 90 days the tissue regained its normal, healthy architecture with multilayered, non‐keratinized epithelium. It can be concluded that the implants developed in this study are promising for clinical use in corneal stroma recovery.

1 February 2024 in Tissue Engineering Part B: Reviews
Verified
Journal Article
Closed access
NÖNeval Sevinç Özdemir
Neval Sevinç Özdemir
DBDmitry Belyaev
Dmitry Belyaev
MCManuel Nieto Castro
Manuel Nieto Castro
SBSascha Balakin
Sascha Balakin
Opitz JoergOpitz Joerg
Opitz Joerg
Vasif HasirciVasif Hasirci
Vasif Hasirci
Respiratory infections caused by coronaviruses (CoVs) have become a major public health concern in the past two decades as revealed by the emergence of SARS-CoV in 2002, MERS-CoV in 2012, and SARS-CoV-2 in 2019. The most severe clinical phenotypes commonly arise from exacerbation of immune response following the infection of alveolar epithelial cells localized at the pulmonary blood-air barrier. Preclinical rodent models do not adequately represent the essential genetic properties of the barrier, thus necessitating the use of humanized transgenic models. However, existing monolayer cell culture models have so far been unable to mimic the complex lung microenvironment. In this respect, air-liquid interface (ALI) models, tissue engineered models, and organ-on-a-chip systems, which aim to better imitate the infection site microenvironment and microphysiology, are being developed to replace the commonly used monolayer cell culture models, and their use is becoming more widespread every day. On the other hand, studies on the development of nanoparticles that mimic respiratory viruses, and those nanoparticles used in therapy are progressing rapidly. The first part of this review describes in vitro models that mimic the blood-air barrier, the tissue interface that plays a central role in COVID-19 progression. In the second part of the review, nanoparticles mimicking the virus and/or designed to carry therapeutic agents are explained and exemplified.

28 December 2023 in Macromolecular Bioscience
Verified
Journal Article
Open access
GKGozde E. Kole
Gozde E. Kole
VHVasif Hasirci
Vasif Hasirci
DYDeniz Yucel
Deniz Yucel
Advances in the development of vascular substitutes for small‐sized arteries are ongoing because the present grafts do not entirely meet the requirements of native equivalents and are suboptimal in clinical performance. This study aims to develop a tri‐layered vascular construct mimicking natural tissue using polyester blends and to investigate its endothelization through in vitro studies as a potential small‐caliber vascular graft. The innermost layer is obtained by dip coating as a tubular porous film with a lumen diameter of 3 mm and a pore size of ≤8 µm. Circumferentially aligned electrospun fiber (diameter 100–800 nm) with a deviation angle of 15° are deposited over the porous film forming the intermediate layer. The random electrospun fibers (diameter 100–1100 nm) deviating at different angles are wrapped as the outermost layer. The mechanical properties of the tri‐layered vascular construct are determined to be 44.80 ± 14.80 MPa for Young's modulus and 4.25 ± 0.75 MPa for ultimate tensile strength. MTS and cell behavior studies show that the isolated human umbilical cord vein endothelial cells proliferate and line the lumen of the vascular substitute. The vascular construct developed, with its biomimetic architecture, mechanical features, size, and endothelization, can be tested with in vivo studies.

24 December 2025 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Open access
PDF file
DADamla Arslantunali-Sahin
Damla Arslantunali-Sahin
DTDilara Goksu Tamay
Dilara Goksu Tamay
SISeyma Isik
Seyma Isik
GKGozde Ervin Kole
Gozde Ervin Kole
EEEkin Erdoğan
Ekin Erdoğan
Vasif HasirciVasif Hasirci
Vasif Hasirci
This study focuses on the design, production and testing of a micropatterned PDMS surface, featuring micropillars and microchannels to study the regeneration of individual axons of PC12 nerve cells after injury. Micropillar organization on the surface was designed to restrict the PC12 cell bodies while axons were guided into microchannels, allowing observation of individual axons. Surfaces were coated with poly(L-lysine) to improve cell attachment and proliferation. Netrin-1, a chemoattractant molecule and axonal elongation enhancer, was introduced in a gelatin methacrylate (GelMA) hydrogel carrier at the opposite end of the channels. Schwann cells (SC) were co-cultured with PC12 cells to enhance axon extension. MTT and Live-Dead assays showed 90% viability of the PC12 and Schwann cells on surfaces. The average PC12 axon length in the channels was 51 ± 19 μm; which increased to 75 ± 16 μm and 177 ± 31 μm upon co-culture with Schwann cells and Netrin-1 incorporation along with co-culturing, respectively, showing their synergistic effect on axon elongation. To study axon damage and regeneration processes, PC12 axons extended into the microchannels were cut using a microtome blade. An increase in the expression of injury markers ATF3, GFAP and S100β was observed after the injury with confocal microscopy, and their decrease from days 14 to 21 indicated the initiation of axon regeneration. The platform consisting of patterned PDMS surface, Schwann cells and Netrin-1 holds potential as a valuable tool for nerve damage and repair studies, and for in vitro testing of novel nerve tissue engineering strategies.

12 June 2026 in Biomaterials Science
Verified
Journal Article
Open access
PDF file
SISeyma Isik
Seyma Isik
DYDeniz Yucel
Deniz Yucel
Vasif HasirciVasif Hasirci
Vasif Hasirci
A bioprinted GBM model consisting of a biomimetic hydrogel within a hypoxia chip reproduced tumor heterogeneity, invasion, and drug resistance, creating a physiologically relevant platform for glioblastoma research.